RPTOR and hepatocellular carcinoma: Previous reports have shown that METTL1 promotes esophageal squamous cell carcinoma through the RPTOR/ULK1/autophagy axis and mediates m7G tRNA modification to promote lenvatinib resistance in hepatocellular carcinoma [33, 34].